Company news
Bonus Biogroup Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Bonus Biogroup Appoints Renowned Cell Therapy Leader, Professor Edwin M. Horwitz, MD, PhD, to its Advisory Board
July 14, 2025
Bonus Biogroup Announces U.S. Food and Drug Administration (FDA) Clearance of an Investigational New Drug (IND) Application for MesenCure™ Phase III Clinical Study in Respiratory Distress
February 20, 2025
Decks
- IPO Roadshow (March 2026)
IPO roadshow · 43 slides · Mar 12, 2026
- Investor Presentation (2025)
Investor deck · 42 slides · 2025
- Investor Presentation (March 2018)
Investor deck · 35 slides · March 2018
- Investor Presentation (August 2016)
Investor deck · 27 slides · August 2016